Your browser doesn't support javascript.
loading
Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan, Yanhong; Wang, Wei; Huang, Shuai; Ni, Wenting; Wei, Zhonghong; Cao, Yuzhu; Yu, Suyun; Jia, Qi; Wu, Yuanyuan; Chai, Chuan; Zheng, Qian; Zhang, Lei; Wang, Aiyun; Sun, Zhiguang; Huang, Shile; Wang, Shijun; Chen, Wenxing; Lu, Yin.
Afiliação
  • Pan Y; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Wang W; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Huang S; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Ni W; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Wei Z; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Cao Y; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Yu S; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Jia Q; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Wu Y; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Chai C; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zheng Q; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zhang L; Department of Pharmacy, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
  • Wang A; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Sun Z; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Huang S; Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
  • Wang S; Shandong Co-innovation Center of TCM Formula, College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Chen W; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Lu Y; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, China.
J Cell Mol Med ; 23(10): 6846-6858, 2019 10.
Article em En | MEDLINE | ID: mdl-31343107

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piruvato Quinase / Sesquiterpenos / Neoplasias da Mama / Núcleo Celular / Multimerização Proteica Tipo de estudo: Prognostic_studies Idioma: En Revista: J Cell Mol Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piruvato Quinase / Sesquiterpenos / Neoplasias da Mama / Núcleo Celular / Multimerização Proteica Tipo de estudo: Prognostic_studies Idioma: En Revista: J Cell Mol Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China